Notably, STAT3 activity in TAMs seems to promote tumorigenesis and therapeutic resistance by supporting the persistence of a population of cancer cells with increased tumorigenic potential, known as cancer stem/initiating cells (84). The gene discussed is STAT3; the disease is cancer.